Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

This publication has 33 references indexed in Scilit:

• A simplePichia pastorisfermentation and downstream processing strategy for making recombinant pandemic Swine Origin Influenza A virus Hemagglutinin protein
  Journal of Industrial Microbiology & Biotechnology, 2013
• A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
  Journal of Virology, 2011
• Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
  Virology Journal, 2010
• Diffusion and Sedimentation Interaction Parameters for Measuring the Second Virial Coefficient and Their Utility as Predictors of Protein Aggregation
  Biophysical Journal, 2010
• A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
  Viral Immunology, 2010
• High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran
  Virology Journal, 2010
• Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
  Virology, 2009
• Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
  Biochemical and Biophysical Research Communications, 2009
• The spike protein of SARS-CoV — a target for vaccine and therapeutic development
  Nature Reviews Microbiology, 2009
• Enhancing the Production of Fc Fusion Protein in Fed-Batch Fermentation of Pichia pastoris by Design of Experiments
  Biotechnology Progress, 2008